









Mercados
/
Ações
/
nasdaq-tech
/

Bio-Techne Corp

TECH

51.850USD

+1.370+2.71%

Fechamento 09/26, 16:00（ET）Cotações atrasadas em 15 min

8.04BValor de mercado

109.53P/L TTM



Bio-Techne Corp

51.850

+1.370+2.71%

Visão Geral Empresa Serviços Financeiros Análises

Visão Geral

Empresa

Serviços Financeiros

Análises

Mais detalhes de Empresa

Informações da empresa

Código da empresaTECH

Nome da EmpresaBio-Techne Corp

Data de listagemFeb 09, 1989

CEOMr. Kim Kelderman

Número de funcionários3100

Tipo de títulosOrdinary Share

Fim do ano fiscalFeb 09

Endereço614 Mckinley Pl N E

CidadeMINNEAPOLIS

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal55413

Telefone16123792956

Sitehttps://www.bio-techne.com/

Código da empresaTECH

Data de listagemFeb 09, 1989

CEOMr. Kim Kelderman

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. John L. Higgins

Independent Director

65.24K

Mr. Kim Kelderman

President, Chief Executive Officer, Director

50.97K

+3.02%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

44.86K

Dr. Roeland Nusse, Ph.D.

Independent Director

44.56K

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

13.77K

Dr. Rupert J. Vessey, Ph.D.

Independent Director

9.35K

Ms. Julie L. Bushman

Independent Director

7.13K

Dr. Matthew F. Mcmanus

President - Diagnostics and Spatial Biology

4.74K

+169.49%

Mr. Shane Bohnen

Senior Vice President, General Counsel, Corporate Secretary

4.38K

Dr. Judith V. Klimovsky, M.D.

Independent Director

2.14K

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. John L. Higgins

Independent Director

65.24K

Mr. Kim Kelderman

President, Chief Executive Officer, Director

50.97K

+3.02%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

44.86K

Dr. Roeland Nusse, Ph.D.

Independent Director

44.56K

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

13.77K

Dr. Rupert J. Vessey, Ph.D.

Independent Director

9.35K

Detalhamento da receita

Moeda: USDAtualizado em: dom, 6 de jul

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Consumables

257.79M

81.53%

Service

27.25M

8.62%

Instruments

26.11M

8.26%

Royalty

5.04M

1.59%

Por RegiãoUSD

Nome

Receita

Proporção

United States

181.92M

57.54%

EMEA, excluding U.K

66.50M

21.03%

Greater China

24.48M

7.74%

APAC, excluding Greater China

21.25M

6.72%

United Kingdom

12.85M

4.06%

Rest of World

9.18M

2.90%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Consumables

257.79M

81.53%

Service

27.25M

8.62%

Instruments

26.11M

8.26%

Royalty

5.04M

1.59%

Distribuição de ações

Atualizado em: ter, 19 de ago

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

11.82%

BlackRock Institutional Trust Company, N.A.

5.65%

T. Rowe Price Associates, Inc.

5.53%

State Street Global Advisors (US)

3.76%

Atlanta Capital Management Company, L.L.C.

2.76%

Outro

70.48%

Investidores

Proporção

The Vanguard Group, Inc.

11.82%

BlackRock Institutional Trust Company, N.A.

5.65%

T. Rowe Price Associates, Inc.

5.53%

State Street Global Advisors (US)

3.76%

Atlanta Capital Management Company, L.L.C.

2.76%

Outro

70.48%

Tipos de investidores

Investidores

Proporção

Investment Advisor

57.35%

Investment Advisor/Hedge Fund

30.62%

Hedge Fund

7.35%

Research Firm

2.52%

Bank and Trust

2.13%

Pension Fund

1.80%

Sovereign Wealth Fund

1.24%

Individual Investor

0.26%

Insurance Company

0.24%

Participação acionária institucional

Atualizado em: ter, 1 de jul

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q2

1209

165.25M

105.41%

-730.33K

2025Q1

1245

168.10M

107.22%

+1.54M

2024Q4

1233

162.21M

102.61%

-6.39M

2024Q3

1205

159.40M

100.49%

-10.21M

2024Q2

1207

160.52M

101.86%

-12.24M

2024Q1

1216

162.56M

103.40%

-7.57M

2023Q4

1229

159.70M

100.98%

-3.97M

2023Q3

1217

156.41M

98.84%

-7.93M

2023Q2

1213

155.36M

98.68%

-4.04M

2023Q1

1206

153.08M

97.33%

-5.18M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

18.46M

11.77%

-66.38K

-0.36%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

9.31M

5.94%

+50.72K

+0.55%

Mar 31, 2025

T. Rowe Price Associates, Inc.

11.14M

7.11%

+717.26K

+6.88%

Mar 31, 2025

State Street Global Advisors (US)

6.53M

4.17%

+57.21K

+0.88%

Mar 31, 2025

Atlanta Capital Management Company, L.L.C.

3.72M

2.37%

+771.93K

+26.18%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.09M

2.61%

+92.10K

+2.30%

Mar 31, 2025

Invesco Capital Management LLC

2.96M

1.89%

+483.60K

+19.50%

Mar 31, 2025

Select Equity Group, L.P.

5.37M

3.42%

+3.03M

+129.77%

Mar 31, 2025

Mairs and Power, Inc.

2.80M

1.78%

-23.04K

-0.82%

Mar 31, 2025

Baron Capital Management, Inc.

3.28M

2.09%

-861.18K

-20.82%

Mar 31, 2025

Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de set

Nome

Proporção

Vanguard ESG U.S. Stock ETF

Harbor Health Care ETF

Innovator Gradient Tactical Rotation Strategy ETF

Global X S&P 500 Risk Managed Income ETF

Global X Genomics & Biotechnology ETF

Calvert US Large-Cap Diversity, Eqty & Inc Idx ETF

Invesco NASDAQ Next Gen 100 ETF

iShares US Industry Rotation Active ETF

First Trust NASDAQ BuyWrite Income ETF

CCM Global Equity ETF

Ver Mais

Vanguard ESG U.S. Stock ETF

Proporção0%

Harbor Health Care ETF

Proporção0%

Innovator Gradient Tactical Rotation Strategy ETF

Proporção0%

Global X S&P 500 Risk Managed Income ETF

Proporção0%

Global X Genomics & Biotechnology ETF

Proporção0%

Calvert US Large-Cap Diversity, Eqty & Inc Idx ETF

Proporção0%

Invesco NASDAQ Next Gen 100 ETF

Proporção0%

iShares US Industry Rotation Active ETF

Proporção0%

First Trust NASDAQ BuyWrite Income ETF

Proporção0%

CCM Global Equity ETF

Proporção0%

Dividendo

Um total de 250.90M USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Feb 05, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025

Feb 17, 2025

Feb 28, 2025

Feb 14, 2025

Oct 30, 2024

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024

Nov 11, 2024

Nov 22, 2024

Nov 08, 2024

Aug 07, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024

Aug 19, 2024

Aug 30, 2024

Aug 19, 2024

May 01, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024

May 13, 2024

May 24, 2024

May 10, 2024

Feb 01, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024

Feb 12, 2024

Feb 26, 2024

Feb 09, 2024

Oct 31, 2023

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 24, 2023 going ex on Nov 09, 2023

Nov 10, 2023

Nov 24, 2023

Nov 09, 2023

Aug 08, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Sep 01, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Sep 01, 2023

Aug 17, 2023

May 03, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 26, 2023 going ex on May 12, 2023

May 15, 2023

May 26, 2023

May 12, 2023

Feb 02, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 27, 2023 going ex on Feb 10, 2023

Feb 13, 2023

Feb 27, 2023

Feb 10, 2023

Nov 01, 2022

TECH.NB Final Cash Dividend of gross USD 0.32 paid on Nov 28, 2022 going ex on Nov 10, 2022

Nov 14, 2022

Nov 28, 2022

Nov 10, 2022

Ver Mais

Desdobramento de ações

Data

Tipo

Proporção

Nov 01, 2022

Split

1→4

Data

Tipo

Proporção

Nov 01, 2022

Split

1→4

KeyAI

